Multi-targeted molecular docking, pharmacokinetic analysis, and drug-likeness evaluation of alkaloids for anti-diabetic drug development
Open Access
- 20 May 2025
- journal article
- Published by Sechenov University in The BRICS Health Journal
- Vol. 2 (1) , 53-68
Abstract
Diabetes mellitus is a global health challenge, particularly in low-income regions, leading to severe complications. Plant-derived alkaloids offer potential as alternatives to conventional therapies. This study evaluated 31 alkaloids for antidiabetic drug development through molecular docking, pharmacokinetics, and drug-likeness analyses. Four standard drugs (epalrestat, metformin, acarbose, glibenclamide) and four targets (aldose reductase, adenosine monophosphate-activated protein kinase, a-glucosidase, protein tyrosine phosphatase 1B) were used for computational simulations.Molecular docking revealed that alkaloids mahanimbine (-11.5 kcal/mol), echinulin (11.3 kcal/mol), coptisine (-10.9 kcal/mol), and groenlandicine (-9.7 kcal/mol) have substantial binding affinities against aldose reductase compared to epalrestat (-9.3 Kcal/mol). In contrast to metformin (-4.8 kcal/mol), coptisine, echinulin, sanguinarine, and groelandicine showed superior binding affinities against adenosine monophosphateactivated protein kinase. In comparison to acarbose (-8.4 Kcal/mol), coptisine (-9.7 Kcal/mol), sanguinarine (-9.3 Kcal/mol), mahanimbine (-8.9 Kcal/mol), and echinulin (-8.9 Kcal/mol) demonstrated better docking scores against a-glucosidase. Jatrorrhizine, coptisine, sanguinarine, mahanimbine and echinuline respectively demonstrated higher binding scores of 8.8, -7.5, -7.5 and -7.2 Kcal/mol against protein tyrosine phosphatase 1B than glibenclamide (-7.0 Kcal/mol). Most alkaloids adhered to Lipinski’s rule, except casuarine 6-O-a-glucoside and conophylline. Pharmacokinetics identified pinoline as highly bioavailable and central nervous system penetrant, while conophylline had poor bioavailability.The study concluded that alkaloids including mahanimbine, echinulin, coptisine, groenlandicine, sanguinarine, and jatrorrhizine show strong binding affinities and favorable pharmacokinetic properties, requiring further in vitro and in vivo studies for therapeutic validationKeywords
This publication has 55 references indexed in Scilit:
- Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 dataDiabetologia, 2022
- Why 90% of clinical drug development fails and how to improve it?Acta Pharmaceutica Sinica B, 2022
- A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetesPhytochemistry Reviews, 2021
- Plant Alkaloids with Antidiabetic Potential2021
- The State of Health System(s) in Africa: Challenges and Opportunities2017
- BDDCS, the Rule of 5 and drugabilityAdvanced Drug Delivery Reviews, 2016
- Screening alpha‐glucosidase and alpha‐amylase inhibitors from natural compounds by molecular docking in silicoBioFactors, 2015
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2012
- Discovery of potential aldose reductase inhibitors using in silico docking studiesAdvances in Traditional Medicine, 2012
- Synthesis, Biological Evaluation and Docking Studies of Casuarine Analogues: Effects of Structural Modifications at Ring B on Inhibitory Activity Towards GlucoamylaseEuropean Journal of Organic Chemistry, 2010